Search research articles
Contact Us
Filters
Showing results (21-30 of 229) with videos related to
Page
of 23
Sort By:
The British Journal of Dermatology
|
August 1, 1997
Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2)
R F Ghohestani, A Claudy
Melanoma Research
|
July 26, 2002
Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin
J Kanitakis, D Narvaez, A Claudy
Presse Medicale (Paris, France : 1983)
|
December 10, 1999
[Cutaneous complications after organ transplant]
S Euvrard, J Kanitakis, A Claudy
Pathologie-Biologie
|
December 1, 1996
[Skin and neuromediators]
L Misery, D Schmitt, A Claudy
The British Journal of Dermatology
|
October 1, 1981
Sclerosing lipogranuloma of the male genitalia: ultrastructural study
A Claudy, F Garcier, D Schmitt
Dermatologica
|
January 1, 1978
[Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)]
N Pelletier, A Claudy, J Thivolet
Anticancer Research
|
January 1, 1997
CD40 expression in epidermal tumors
J Viac, D Schmitt, A Claudy
Lancet (London, England)
|
August 11, 2001
Clinical picture: eyelid metastasis
J Kanitakis, M Faure, A Claudy
Anticancer Research
|
December 29, 2000
Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin
J Kanitakis, D Bourchany, A Claudy
Acta Dermato-Venereologica
|
February 24, 2001
Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity
J Viac, D Schmitt, A Claudy
Page
of 23
Search research articles
Search
Showing results (21-30 of 229) with videos related to
Sort By:
Page
of 23
The British Journal of Dermatology
|
August 1, 1997
Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2)
R F Ghohestani, A Claudy
Melanoma Research
|
July 26, 2002
Differential expression of the CD10 antigen (neutral endopeptidase) in primary versus metastatic malignant melanomas of the skin
J Kanitakis, D Narvaez, A Claudy
Presse Medicale (Paris, France : 1983)
|
December 10, 1999
[Cutaneous complications after organ transplant]
S Euvrard, J Kanitakis, A Claudy
Pathologie-Biologie
|
December 1, 1996
[Skin and neuromediators]
L Misery, D Schmitt, A Claudy
The British Journal of Dermatology
|
October 1, 1981
Sclerosing lipogranuloma of the male genitalia: ultrastructural study
A Claudy, F Garcier, D Schmitt
Dermatologica
|
January 1, 1978
[Evaluation of prognostic factors in malignant melanoma according to the actuarial method: report of 75 cases (author's transl)]
N Pelletier, A Claudy, J Thivolet
Anticancer Research
|
January 1, 1997
CD40 expression in epidermal tumors
J Viac, D Schmitt, A Claudy
Lancet (London, England)
|
August 11, 2001
Clinical picture: eyelid metastasis
J Kanitakis, M Faure, A Claudy
Anticancer Research
|
December 29, 2000
Expression of the CD10 antigen (neutral endopeptidase) by mesenchymal tumors of the skin
J Kanitakis, D Bourchany, A Claudy
Acta Dermato-Venereologica
|
February 24, 2001
Plasma vascular endothelial growth factor levels in scleroderma are not correlated with disease activity
J Viac, D Schmitt, A Claudy
Page
of 23